Pratt Vicky

Dr. Pratt is the Past President of Association for Molecular Pathology.  Dr. Pratt continues to serve on the Centers for Disease Control and Prevention (CDC) GeT-RM program for reference materials for Molecular Genetics, the National Academy of Medicine’s Roundtable on Genomics and Precision Health, and the American Medical Association’s (AMA) Current Procedural Terminology (CPT) Advisory committee.

 

Dr. Pratt graduated with a Ph.D. in Medical and Molecular Genetics from Indiana University School of Medicine.  Her fellowship training was in Ph.D. Medical and Clinical Molecular Genetics at Henry Ford Hospital, Detroit MI.

Association for Molecular Pathology’s Recommendations for clinical pharmacogenotyping allele selection

Testing for pharmacogenetic/genomic (PGx) variants is a rapidly growing area of research and clinical testing.  Many testing platforms include a variety of research and clinically relevant variants.  Many of these platforms do not include variants that are applicable to all genetic ancestries.  The Association for Molecular Pathology (AMP) is leading an international effort to standardize which PGx variants are included in clinical testing and research.